Targeting the neuropeptide Y<sub>1</sub> (Y<sub>1</sub>R) and Y<sub>2</sub> (Y<sub>2</sub>R) receptors has gained interest in treating weight and mental disorders. The gene discussed is NPY; the disease is psychiatric disorder.